In Practice/In Context™

HIV Updates and Insights

Clinical Practice Guidelines

Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living With HIV.

US Department of Health and Human Services, 2017 (last updated October 2018).

Guidelines for Managing Advanced HIV Disease and Rapid Initiation of Antiretroviral Therapy.

World Health Organization. Geneva, 2017.

HIV Testing Implementation: Guidance for Correctional Settings.

Centers for Disease Control and Prevention (CDC), 2009.

Management of HIV Infection.

Federal Bureau of Prisons, 2018.

Patients With HIV/HCV Coinfection.

American Association for the Study of Liver Diseases/Infectious Diseases Society of America, 2018.

Preexposure Prophylaxis for the Prevention of HIV Infection in the United States—2017 Update.

CDC/United States Public Health Service. 2018.

Reentry Support Guidelines.

Substance Abuse and Mental Health Services Administration (SAMHSA).

Clinical Resources

Correctional Health Linkage Interventions.

TargetHIV: Integrating HIV Innovative Practices, 2013.

Database of Antiretroviral Drug Interactions.

HIV InSite. University of California, San Francisco, 2018.

Hampden County Correctional Center.

Hampden County Sheriff’s Department, 2018.

Harm Reduction.

Harm Reduction Coalition, 2018.

Provider Resources.

American Academy of HIV Medicine, 2018.

Reentry Resources for Individuals, Providers, Communities, and States.

SAMHSA, 2016.

Transitional Healthcare Coordination.

City of New York. NYC Health, 2018.

Understanding the HIV Care Continuum.

CDC, 2018.

Suggested Readings

Understanding the relationship between social support and physical and mental well-being among jail detainees living with HIV.

Arriola KJ, et al. J Health Psychol. 2015;20(1):3-12.

Jails as an opportunity to increase engagement in HIV care: findings from an observational cross-sectional study.

Avery AK, et al. AIDS Behav. 2013;17(suppl 2):S137-S144.

Opportunities to diagnose, treat, and prevent HIV in the criminal justice system.

Beckwith CG, et al. J Acquir Immune Defic Syndr. 2010;55(suppl 1):S49-S55.

The path to implementation of HIV pre-exposure prophylaxis for people involved in criminal justice systems.

Brinkley-Rubinstein L, et al. Curr HIV/AIDS Rep. 2018;15(2):93-95.

Contribution of substance use disorders on HIV treatment outcomes and antiretroviral medication adherence among HIV-infected persons entering jail.

Chitsaz E, et al. AIDS Behav. 2013;17(suppl 2):S118-S127.

Assessing the effect of recent incarceration in prison on HIV care retention and viral suppression in two states.

Costa M, et al. J Urban Health. 2018;95(4):499-507.

Can TasP approaches be implemented in correctional settings? A review of HIV testing and linkage to community HIV treatment programs.

Elkington KS. J Health Care Poor Underserved. 2016;27(2A):71-100.

Understanding the revolving door: individual and structural level predictors of recidivism among individuals with HIV leaving jail.

Fu JJ. AIDS Behav. 2013;17(suppl 2):S145-S155.

The HIV care cascade before, during, and after incarceration: a systematic review and data synthesis.

Iroh PA, et al. Am J Public Health. 2015;105(7):e5-e16.

Practical guidance for nonoccupational postexposure prophylaxis to prevent HIV infection: an editorial review.

Jain S, Mayer KH. AIDS. 2014;28(11):1545-1554.

Transitional care coordination in New York City jails: facilitating linkages to care for people with HIV returning home from Rikers Island.

Jordan AO, et al. AIDS Behav. 2013.17(suppl 2):S212-S219.

U.S. Supreme Court. Estelle v. Gamble, 429 U.S. 97 (1976).

Justia U.S. Supreme Court.

Post-release substance abuse outcomes among HIV-infected jail detainees: results from a multisite study.

Krishnan A, et al. AIDS Behav. 2013.17(suppl 2):S171-S180.

U=U is taking off in 2017 (editorial).

The Lancet HIV. 2017;4(11):e475.

Predictors of linkage to HIV care and viral suppression after release from jails and prisons: a retrospective cohort study.

Loeliger KB, et al. Lancet HIV. 2018;5(2):e96-e106.

Evaluation of a prisoner condom access pilot program conducted in one California state prison facility.

Lucas KD, et al. Office of AIDS, Center for Infectious Diseases, California Department of Public Health, 2011.

Opportunities to prevent overdose deaths involving prescription and illicit opioids, 11 states, July 2016–June 2017.

Mattson CL, et al. MMWR Morb Mortal Wkly Rep. 2018;67(34):945-951.

Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate.

Mayer JP. JAMA Intern Med. 2014;174(5):721-729.

“Inside these fences is our own little world”: prison-based HIV testing and HIV-related stigma among incarcerated men and women.

Muessig K, et al. AIDS Educ Prev. 2016;28(2):103-116.

The monthly shaming of women in state prisons.

Polka E. Public Health Post. September 4, 2018.

HIV preexposure prophylaxis: a review.

Riddell J IV, et al. JAMA. 2018; 319(12):1261-1268.

HIV, prisoners, and human rights.

Rubenstein LS, et al. Lancet. 2016;388(10050):1202-1214.

US prisons missing opportunities to tackle HIV in inmates.

Rubin R. Lancet. 2016;388(10049):1041-1042.

Cost analysis of enhancing linkages to HIV care following jail: a cost-effective intervention.

Spaulding AC, et al. AIDS Behav. 2013;17(suppl 2):S220-S226.

Jails, HIV testing, and linkage to care services: an overview of the EnhanceLink initiative.

Spaulding AC, et al. AIDS Behav. 2013;17(suppl 2):S100-S107.

Planning for success predicts virus suppressed: results of a non-controlled, observational study of factors associated with viral suppression among HIV-positive persons following jail release.

Spaulding AC, et al. AIDS Behav. 2013;17(suppl 2):S203-S211.

HIV-positive and in jail: race, risk factors, and prior access to care.

Stein MS, et al. AIDS Behav. 2013;17(suppl 2):S108-S117.

Opening the door to zero new HIV infections in closed settings.

Torriente A, et al. Health Hum Rights. 2016;18(1):157-168.

HIV risk inside U.S. prisons: a systematic review of risk reduction interventions conducted in U.S. prisons.

Valera P, et al. AIDS Care. 2017;29(8):943-952.

HIV among marginalized populations in Rhode Island (Project Bridge).

Wakeman SE, et al. Med Health R I. 2009;92(7):244-246.

Randomized controlled trial of an intervention to maintain suppression of HIV viremia after prison release: the imPACT trial.

Wohl DA, et al. J Acquir Immune Defic Syndr. 2017;75(1):81-90.

Emerging and underrecognized complications of illicit drug use.

Wurcel AG, et al. Clin Infect Dis. 2015;61(12):1840-1849.

HIV Updates and Insights

Realities, Challenges, and Opportunities to Improve Care

Relevant Resources

PrEP for Your Patients’ Needs

The PCPs Role in Preventing HIV

Value-Based HIV Formularies

Optimizing Use of Clinical Evidence & Pharmacoeconomic Models in Managed Care

Hepatitis C is Curable

Got it? Treat it!

Real-World Issues in HIV Prevention & Treatment

The Critical Role of the Community Pharmacist


Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships.

Evolving Models of HIV Care

Volume 1: Rapid ART Initiation: A New Addition to the HIV-Care Tool Box

Updates in HCV Screening and Treatment

Key Issues Impacting OB/GYN Practice

Clinical Issues in Chronic Liver Disease

Hot Topics in HBV, HCV, and NASH

Evolving Models of HIV Care

Volume II: Expanding Evidence for the Role of Rapid ART Initiation in HIV Practice

Assessing Your Patients for HCV and HIV

Why It Matters in OB/GYN Practice Today

HIV as a Chronic Disease

A Treater’s Guide to Optimizing Care in the Aging Patient with Comorbidities

The Pursuit of Hepatitis C Elimination

How the Pharmacist Can Make a Difference

Trends in Infectious Diseases: Updates on Treatment & Prevention Strategies for HIV and HCV

Understanding the Growing Syndemic — Opioids, HCV, and HIV

Stepping Up to the Challenge

The PCP’s Role in HCV Elimination

The Changing Landscape of HIV Prevention

What the Pharmacist Needs to Know about PrEP

Evolving Models of HIV Care (Volume 3)

The Rapid ART Standard of Care: From Evidence to Healthcare Equity

HIV Updates for Pharmacy Practice

Maximizing Your Role to Impact Patient Outcomes


Building Bridges to Reach People Who Inject Drugs With the Goal to Eliminate HCV

Case Challenges in HIV Medicine

Benefits, Barriers, & Best Practices in an Advancing Field

Challenges and Opportunities in HIV

Practical Solutions Across the Spectrum of Care

A Critical Appraisal of Non-Invasive Technologies in NASH

Informing the Future of NASH Diagnosis and Assessment

Expanding HIV Prevention in Colorado—and Nationwide

A PEP/PrEP Training Guide for Pharmacists

Treating Hepatitis C in the Primary Care Setting

A Critical Step Toward HCV Elimination

Honing Clinical Skills in HIV Treatment

Considering the Patient, the Provider, and the Science

Hot Topics in HCV

A Multidisciplinary Online Mini-Curriculum

Clinical Issues in COVID-19

Debates and Discussions about Monoclonal Antibody Therapies

Minimizing Patient Risks From COVID-19

An Update on Monoclonal Antibody Therapies

Treating Hepatitis C in the Primary Care Setting

Establishing Clinical Readiness Through Mentored Learning

Clinical Updates in COVID-19

Recent Developments in Anti-SARS-CoV-2 Monoclonal Antibodies for Treatment

Monoclonal Antibodies for COVID-19

An Update on Best Practices

Monoclonal Antibodies for COVID-19

New Avenues to Pre-Exposure Prophylaxis

Virologic Failure in HIV

An Updated Clinician’s Guide to Assessment and Management

Applying HIV Advances in Practice

What the Pharmacist Needs to Know

Buffing Up on New and Emerging ART

A Look at the Changing HIV Playing Field

Pharmacy PrEP Education

A “How To” Series Spanning Policy to Practice


Building Bridges to Reach People who Inject Drugs with the Goal of Employing PrEP for HIV Prevention

Long-Acting Injectable PrEP:

Bringing HIV Prevention to a New Level

PrEParing to End the Epidemic

Optimizing HIV Prevention in Primary Care

A Call to Action

Monoclonal Antibodies for the Prevention and Treatment of COVID-19

Answers to Everyday Practice Challenges in HIV Medicine

A Phone-a-Friend CME Series – Volume 2

What’s New in the Management of COVID-19

Incorporating New Data and Updated Guidelines Into Daily Practice